benzyl 2-(2-methyl-1H-indol-3-yl)acetate | 502607-41-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: benzyl 2-(2-methyl-1H-indol-3-yl)acetate
• 英文别名: 2-(2-methylindol-3-yl)acetic acid benzyl ester；benzyl (2-methyl-1H-indol-3-yl)acetate
• CAS: 502607-41-2
• 化学式: C₁₈H₁₇NO₂
• 分子量: 279.338
• InChiKey: LJAVXONZNJWULZ-UHFFFAOYSA-N

物化性质

• 沸点：
  458.8±35.0 °C(Predicted)
• 密度：
  1.205±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  21
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  42.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  benzyl 2-(2-methyl-1H-indol-3-yl)acetate 在 palladium 10% on activated carbon 、 potassium tert-butylate 、 氢气 作用下， 以 四氢呋喃 、 乙酸乙酯 为溶剂， 反应 3.25h， 生成 2-[1-(4-氯苯甲酰基)-2-甲基吲哚-3-基]乙酸
  参考文献：
  名称：

  沸石中明确定义的贵金属单中心作为不溶性金属盐催化的替代品

  摘要：

  聚合形式的不溶性贵金属氯化物（即 PtCl2、PdCl2、AuCl、RhCl3）通常用作溶液中大量有机反应的催化剂。在这里，我们表明只有这些贵金属氯化物的少量可溶部分（通常为 5-30%）对炔烃和烯烃的加氢胺化、加氢烷氧基化、氢化硅烷化和环异构化具有催化活性，而其余的不溶性金属在催化上是无用的。为了避免这种贵金属的浪费并遵循合理的设计，我们在沸石 Y 上生成了分散良好的 Pt(II) 和 Pd(II) 单点，并巧妙地控制了路易斯酸度，

  DOI：

  10.1021/jacs.5b07304
• 作为产物：
  描述：

  2-碘苯胺 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodide 、 正丁基锂 、 三乙胺 、 zinc(II) chloride 作用下， 以 四氢呋喃 、 正己烷 、 甲苯 为溶剂， 反应 40.0h， 生成 benzyl 2-(2-methyl-1H-indol-3-yl)acetate
  参考文献：
  名称：

  沸石中明确定义的贵金属单中心作为不溶性金属盐催化的替代品

  摘要：

  聚合形式的不溶性贵金属氯化物（即 PtCl2、PdCl2、AuCl、RhCl3）通常用作溶液中大量有机反应的催化剂。在这里，我们表明只有这些贵金属氯化物的少量可溶部分（通常为 5-30%）对炔烃和烯烃的加氢胺化、加氢烷氧基化、氢化硅烷化和环异构化具有催化活性，而其余的不溶性金属在催化上是无用的。为了避免这种贵金属的浪费并遵循合理的设计，我们在沸石 Y 上生成了分散良好的 Pt(II) 和 Pd(II) 单点，并巧妙地控制了路易斯酸度，

  DOI：

  10.1021/jacs.5b07304

文献信息

• INDOLE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1600440A1

  公开（公告）日：2005-11-30

  An indole derivative compound represented by formula (I) (wherein the symbols in the formula are as mentioned in the specification) and a salt thereof Since the compounds represented by formula (I) binds to PGD2 receptors and shows antagonistic activity, they are believed to be useful for prevention and/or treatment of diseases such as allergic disease (such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mastocytosis, systemic mast cell activating disorder, anaphylaxis shock, airway contraction, urticaria, eczema, diseases accompanied by itch (such as atopic dermatitis, urticaria), diseases (such as cataract, retinal detachment, inflammation, infection and sleep disorder) which are generated secondarily as a result of behavior accompanied by itch (such as scratching and beating), inflammation, chronic obstructive pulmonary diseases, ischemic reperfusion injury, cerebrovascular accident, autoimmune disease, chronic articular rheumatism, pleuritis, ulcerative colitis and irritable bowel syndrome.

  公式（I）所代表的吲哚衍生物化合物及其盐由于公式（I）所代表的化合物结合到PGD2受体并显示拮抗活性，因此认为它们对预防和/或治疗过敏疾病（如过敏性鼻炎、过敏性结膜炎、特应性皮炎、支气管哮喘和食物过敏）、全身组织细胞增生症、全身组织细胞活化障碍、过敏性休克、气道收缩、荨麻疹、湿疹、伴有瘙痒的疾病（如特应性皮炎、荨麻疹）、由于伴有瘙痒行为（如搔抓和敲打）而次生产生的疾病（如白内障、视网膜脱离、炎症、感染和睡眠障碍）、炎症、慢性阻塞性肺疾病、缺血再灌注损伤、脑血管意外、自身免疫疾病、慢性关节风湿病、胸膜炎、溃疡性结肠炎和肠易激综合征等疾病的预防和/或治疗可能是有用的。
• Indole derivatives, process for preparation of the same and use thereof
  申请人：——

  公开号：US20030176400A1

  公开（公告）日：2003-09-18

  Indole derivatives represented by formula (I): 1 (wherein all symbols are described in the description), a process for the preparation of the same and a DP receptor antagonist comprising it as an active ingredient. Since the compounds of formula (I) binds to and are antagonistic to a DP receptor, they are useful in for the prevention and/or treatment of diseases, for example, allergic diseases (allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, etc., systemic mastocytosis; disorders due to systemic mastocyte activation, anaphylactic shock, bronchoconstriction, urticaria, eczema, etc.), diseases accompanied with itching (atopic dermatitis, urticaria, etc.), secondary diseases caused by behaviors (scratching behaviors, beating, etc.) (cataract, retinal detachment, inflammation, infection, sleep disorder, etc.), inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, cerebrovascular disorder, pleuritis complicated by rheumatoid arthritis, ulcerative colitis, and the like.

  Indole 衍生物的化学式（I）：1（其中所有符号在描述中有描述），以及制备该化合物的方法和作为活性成分的 DP 受体拮抗剂。由于化合物的化学式（I）与 DP 受体结合并具有拮抗作用，因此它们在预防和/或治疗疾病方面非常有用，例如过敏性疾病（过敏性鼻炎、过敏性结膜炎、特应性皮炎、支气管哮喘、食物过敏等）、全身肥大细胞增多症；由于全身肥大细胞激活引起的疾病、过敏性休克、支气管痉挛、荨麻疹、湿疹等）、伴有瘙痒的疾病（特应性皮炎、荨麻疹等）、由行为引起的继发性疾病（搔抓行为、殴打等）（白内障、视网膜脱离、炎症、感染、睡眠障碍等）、炎症、慢性阻塞性肺病、缺血再灌注障碍、脑血管障碍、风湿性关节炎并发的胸膜炎、溃疡性结肠炎等。
• Aromatic Enamide/Ene Metathesis toward Substituted Indoles and Its Application to the Synthesis of Indomethacins
  作者：Yayoi Kasaya、Kosuke Hoshi、Yukiyoshi Terada、Atsushi Nishida、Satoshi Shuto、Mitsuhiro Arisawa

  DOI：10.1002/ejoc.200900520

  日期：2009.9

  A steric and electronic effect on enamide/ene metathesis, a novel preparation of 2-substituted indoles and 3-substituted indoles using enamide-ene metathesis as a key reaction, and its application to the synthesis of indomethacin are described. (© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)

  描述了烯酰胺/烯复分解的空间和电子效应，使用烯酰胺 - 烯复分解作为关键反应制备 2-取代吲哚和 3-取代吲哚的新方法，及其在吲哚美辛合成中的应用。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2009)
• Indole derivatives
  申请人：Torisu Kazuhiko

  公开号：US20050004097A1

  公开（公告）日：2005-01-06

  Compounds represented by formula (I) wherein all symbols represent the same meanings as described in specification. and salts thereof. Since the compound represented by the formula (I) binds and antagonizes to DP receptor, it is useful for the prevention or treatment against the disease such as allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease, and ulcerative colitis.

  化学式为（I）的化合物及其盐，其中所有符号的含义如规范中所述。由于化学式（I）所代表的化合物能够结合和拮抗DP受体，因此它对于预防或治疗过敏性疾病、伴随瘙痒的疾病、由于瘙痒引起的行为所导致的继发性疾病、炎症、慢性阻塞性肺疾病、缺血再灌注障碍、风湿性关节炎并发的胸膜炎、脑血管疾病和溃疡性结肠炎等疾病具有用处。
• INDOLE DERIVATIVES, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF
  申请人：ONO PHARMACEUTICAL CO., LTD.

  公开号：EP1262475A1

  公开（公告）日：2002-12-04

  Indole derivatives represented by formula (I): (wherein all symbols are described in the description), a process for the preparation of the same and a DP receptor antagonist comprising it as an active ingredient. Since the compounds of formula (I) binds to and are antagonistic to a DP receptor, they are useful in for the prevention and/or treatment of diseases, for example, allergic diseases (allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, etc., systemic mastocytosis; disorders due to systemic mastocyte activation, anaphylactic shock, bronchoconstriction, urticaria, eczema, etc.), diseases accompanied with itching (atopic dermatitis, urticaria, etc.), secondary diseases caused by behaviors (scratching behaviors, beating, etc.) (cataract, retinal detachment, inflammation, infection, sleep disorder, etc.), inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, cerebrovascular disorder, pleuritis complicated by rheumatoid arthritis, ulcerative colitis, and the like.

  由式（I）代表的吲哚衍生物： 式（I）代表的吲哚衍生物（其中所有符号已在描述中说明）、制备该衍生物的工艺以及以其为活性成分的 DP 受体拮抗剂。由于式 (I) 化合物与 DP 受体结合并对其具有拮抗作用，因此可用于预防和/或治疗疾病，例如过敏性疾病（过敏性鼻炎、过敏性结膜炎、特应性皮炎、支气管哮喘、食物过敏等）、系统性肥大细胞增多症、过敏性结膜炎、过敏性皮炎、支气管哮喘、食物过敏等、全身性肥大细胞增多症；全身性肥大细胞活化引起的疾病、过敏性休克、支气管收缩、荨麻疹、湿疹等）、伴有瘙痒的疾病（异位性皮炎、荨麻疹等）、由行为（抓挠行为、殴打等）引起的继发性疾病（白内障、视网膜病变等）。白内障、视网膜脱落、炎症、感染、睡眠障碍等）、炎症、慢性阻塞性肺病、缺血再灌注障碍、脑血管障碍、类风湿性关节炎并发胸膜炎、溃疡性结肠炎等。